Literature DB >> 21843264

Radiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreas.

Matthew R Porembka1, William G Hawkins, David C Linehan, Feng Gao, Changqing Ma, Elizabeth M Brunt, Steven M Strasberg.   

Abstract

OBJECTIVE: The need for mesenteric venous resection (MVR) is determined by a combination of preoperative radiologic and intraoperative surgical assessments. A single-centre review was performed to determine how efficient these processes are in evaluating the need for MVR.
METHODS: A retrospective study was performed of 343 patients who received resection for adenocarcinoma of the head of the pancreas, 100 of whom underwent MVR. Three radiologic signs (abutment, fat plane obliteration, focal narrowing) were evaluated for their ability to predict the need for MVR. Pathologic assessment was performed to determine if MVR had been necessary to achieve negative-margin (R0) resection. Microscopic tumour in the vein wall, or within 1 mm of the vein wall, was considered to indicate that MVR had been necessary to achieve an R0 resection.
RESULTS: Radiologic evaluation (showing any of the three signs) had sensitivity of only 60%. Overall, 40% of the patients who required MVR showed none of the signs. Specificity was 77%. A total of 80% of patients who underwent MVR had either microscopic invasion or abutment. R0 resection at the vein margin was achieved in 98% of patients in both the MVR and non-MVR groups.
CONCLUSIONS: Preoperative radiologic evaluation is not highly reliable in predicting the need for MVR. Therefore, surgical teams performing resections of cancers of the head of the pancreas must be skilled in MVR as the need for this procedure may arise unexpectedly. Surgical assessment of the need for MVR has an accuracy of about 80% and is nearly 100% accurate in determining when MVR is not required.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21843264      PMCID: PMC3183448          DOI: 10.1111/j.1477-2574.2011.00343.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  57 in total

Review 1.  Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?

Authors:  P Bachellier; H Nakano; P D Oussoultzoglou; J C Weber; K Boudjema; P D Wolf; D Jaeck
Journal:  Am J Surg       Date:  2001-08       Impact factor: 2.565

2.  Pancreatic adenocarcinoma: signs of vascular invasion determined by multi-detector row CT.

Authors:  H Li; M S Zeng; K R Zhou; D Y Jin; W H Lou
Journal:  Br J Radiol       Date:  2006-07-05       Impact factor: 3.039

3.  Redefining resection margin status in pancreatic cancer.

Authors:  Caroline S Verbeke; Krishna V Menon
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

4.  Redefining the R1 resection in pancreatic cancer.

Authors:  C S Verbeke; D Leitch; K V Menon; M J McMahon; P J Guillou; A Anthoney
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

5.  CT criteria for venous invasion in patients with pancreatic head carcinoma.

Authors:  S S Phoa; J W Reeders; J Stoker; E A Rauws; D J Gouma; J S Laméris
Journal:  Br J Radiol       Date:  2000-11       Impact factor: 3.039

6.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Authors:  Jennifer F Tseng; Chandrajit P Raut; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Henry F Gomez; Charlotte C Sun; Christopher H Crane; Robert A Wolff; Douglas B Evans
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

7.  Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Kazuaki Shimada; Tsuyoshi Sano; Yoshihiro Sakamoto; Tomoo Kosuge
Journal:  Ann Surg Oncol       Date:  2006-12       Impact factor: 5.344

8.  Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas.

Authors:  J F Pingpank; J P Hoffman; E A Ross; H S Cooper; N J Meropol; G Freedman; W H Pinover; T E LeVoyer; A R Sasson; B L Eisenberg
Journal:  J Gastrointest Surg       Date:  2001 Mar-Apr       Impact factor: 3.452

9.  Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.

Authors:  R C van Geenen; F J ten Kate; L T de Wit; T M van Gulik; H Obertop; D J Gouma
Journal:  Surgery       Date:  2001-02       Impact factor: 3.982

10.  Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head.

Authors:  Thomas J Howard; Nicholas Villanustre; Seth A Moore; John DeWitt; Julia LeBlanc; Dean Maglinte; Lee McHenry
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more
  8 in total

1.  Surgical, survival, and oncological outcomes after vascular resection in robotic and open pancreaticoduodenectomy.

Authors:  Bor-Uei Shyr; Shih-Chin Chen; Yi-Ming Shyr; Shin-E Wang
Journal:  Surg Endosc       Date:  2019-04-08       Impact factor: 4.584

2.  Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.

Authors:  N Volkan Adsay; Olca Basturk; Burcu Saka; Pelin Bagci; Denizhan Ozdemir; Serdar Balci; Juan M Sarmiento; David A Kooby; Charles Staley; Shishir K Maithel; Rhonda Everett; Jeanette D Cheng; Duangpeng Thirabanjasak; Donald W Weaver
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

3.  Resection of tumors of the neck of the pancreas with venous invasion: the "Whipple at the Splenic Artery (WATSA)" procedure.

Authors:  Steven M Strasberg; Luis A Sanchez; William G Hawkins; Ryan C Fields; David C Linehan
Journal:  J Gastrointest Surg       Date:  2012-03-08       Impact factor: 3.452

4.  Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?

Authors:  Kaitlyn J Kelly; Emily Winslow; David Kooby; Neha L Lad; Alexander A Parikh; Charles R Scoggins; Syed Ahmad; Robert C Martin; Shishir K Maithel; H J Kim; Nipun B Merchant; Clifford S Cho; Sharon M Weber
Journal:  J Gastrointest Surg       Date:  2013-04-26       Impact factor: 3.452

Review 5.  Classification and techniques of en bloc venous reconstruction for pancreaticoduodenectomy.

Authors:  Farzad Alemi; Flavio G Rocha; William S Helton; Thomas Biehl; Adnan Alseidi
Journal:  HPB (Oxford)       Date:  2016-07-12       Impact factor: 3.647

6.  Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study.

Authors:  George A Poultsides; Thuy B Tran; Eduardo Zambrano; Lucas Janson; David G Mohler; Matthew W Mell; Raffi S Avedian; Brendan C Visser; Jason T Lee; Kristen Ganjoo; E John Harris; Jeffrey A Norton
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

7.  Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.

Authors:  Alexandra M Roch; Michael G House; Jessica Cioffi; Eugene P Ceppa; Nicholas J Zyromski; Attila Nakeeb; C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2016-01-14       Impact factor: 3.452

8.  Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.

Authors:  Y Kishi; S Nara; M Esaki; N Hiraoka; K Shimada
Journal:  BJS Open       Date:  2019-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.